High Point Advisor Group LLC Zoetis Inc. Transaction History

High Point Advisor Group LLC

$1.75 Billion
Q4 2024

A detailed history of High Point Advisor Group LLC transactions in Zoetis Inc. stock. As of the latest transaction made, High Point Advisor Group LLC holds 25,001 shares of ZTS stock, worth $3.94 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

25,001

Previous 12,093 106.74%

Holding current value

$3.94 Million

Previous $2.36 Million 72.44%

% of portfolio

0.23%

Previous 0.14%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$162.24 - $194.42 $2.09 Million - $2.51 Million	12,908 Added 106.74%	25,001 $4.07 Million
Q3 2024 Nov 04, 2024	SELL	$172.58 - $196.48 $237,124 - $269,963	-1,374 Reduced 10.2%	12,093 $2.36 Million
Q2 2024 Aug 08, 2024	BUY	$145.54 - $178.83 $590,164 - $725,155	4,055 Added 43.08%	13,467 $2.33 Million
Q1 2024 May 14, 2024	SELL	$165.67 - $199.94 $53,677 - $64,780	-324 Reduced 3.33%	9,412 $1.59 Million
Q4 2023 Mar 26, 2024	BUY	$151.44 - $200.09 $194,146 - $256,515	1,282 Added 15.16%	9,736 $1.92 Million
Q2 2022 Aug 15, 2022	SELL	$155.97 - $200.09 $241,753 - $310,139	-1,550 Reduced 15.49%	8,454 $1.51 Million
Q3 2021 Nov 15, 2021	BUY	$189.29 - $209.69 $85,180 - $94,360	450 Added 4.71%	10,004 $1.94 Million
Q2 2021 Jul 29, 2021	BUY	$155.9 - $187.99 $400,039 - $482,382	2,566 Added 36.72%	9,554 $1.78 Million
Q1 2021 Apr 12, 2021	BUY	$144.0 - $169.39 $90,000 - $105,868	625 Added 9.82%	6,988 $1.12 Million
Q4 2020 Feb 10, 2021	BUY	$157.07 - $174.35 $268,275 - $297,789	1,708 Added 36.69%	6,363 $1.02 Million
Q3 2020 Nov 06, 2020	SELL	$137.1 - $165.37 $5,621 - $6,780	-41 Reduced 0.87%	4,655 $796,000
Q2 2020 Aug 13, 2020	BUY	$111.92 - $142.53 $63,122 - $80,386	564 Added 13.65%	4,696 $644,000
Q1 2020 May 01, 2020	BUY	$92.66 - $144.94 $334,687 - $523,523	3,612 Added 694.62%	4,132 $520,000
Q1 2020 Apr 27, 2020	SELL	$92.66 - $144.94 $333,390 - $521,494	-3,598 Reduced 87.37%	520 $4.13 Million
Q4 2019 Feb 13, 2020	BUY	$116.25 - $133.25 $26,505 - $30,381	228 Added 5.86%	4,118 $583,000
Q3 2019 Nov 12, 2019	BUY	$112.57 - $128.43 $32,870 - $37,501	292 Added 8.12%	3,890 $458,000
Q2 2019 Aug 15, 2019	BUY	$97.98 - $114.28 $37,526 - $43,769	383 Added 11.91%	3,598 $417,000
Q1 2019 May 08, 2019	BUY	$81.56 - $100.67 $55,705 - $68,757	683 Added 26.97%	3,215 $325,000
Q4 2018 Feb 20, 2019	BUY	$79.28 - $95.27 $6,421 - $7,716	81 Added 3.3%	2,532 $240,000
Q3 2018 Oct 24, 2018	BUY	$83.5 - $93.23 $1,670 - $1,864	20 Added 0.82%	2,451 $227,000
Q2 2018 Aug 20, 2018	SELL	$79.9 - $89.2 $4,634 - $5,173	-58 Reduced 2.33%	2,431 $223,000
Q1 2018 Jun 11, 2018	BUY	$71.51 - $84.69 $177,988 - $210,793	2,489 New	2,489 $216,000

Others Institutions Holding ZTS

# of Institutions

2,031

Shares Held

416M

Call Options Held

1.23M

Put Options Held

1.3M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $73.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.

Account

High Point Advisor Group LLC Zoetis Inc. Transaction History